Parasites and microorganisms associated with the snakes collected for the “ < i > festa Dei serpari < /i > ” in Cocullo, Italy
by Jairo Alfonso Mendoza-Roldan, Livia Perles, Ernesto Filippi, Nicole Szafranski, Gianpaolo Montinaro, Mariaelisa Carbonara, Riccardo Scalera, Pedro Paulo de Abreu Teles, Julia Walochnik, Domenico Otranto
While in much of the Western world snakes are feared, in the small, rural, mountainous town of Cocullo, in the middle of central Italy, snakes are annually collected and celebrated in a sacro-profane ritual. Every 1st of May,Serpari (snake catchers) capture and showcase dozens of non-venomous snakes to celebrate the ritual ofSan Domenico. In order to detect potential zoonotic pathogens within this unique epidemiological...
Source: PLoS Neglected Tropical Diseases - February 21, 2024 Category: Tropical Medicine Authors: Jairo Alfonso Mendoza-Roldan Source Type: research
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia
CONCLUSION: Anaplasmataceae may play an aetiological role in fibromyalgia.PMID:38375844 | DOI:10.2174/0118715273274091231207101522 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - February 20, 2024 Category: Drugs & Pharmacology Authors: Basant K Puri Rosemarie Preyer Gary S Lee Armin Schwarzbach Source Type: research
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia
CONCLUSION: Anaplasmataceae may play an aetiological role in fibromyalgia.PMID:38375844 | DOI:10.2174/0118715273274091231207101522 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - February 20, 2024 Category: Drugs & Pharmacology Authors: Basant K Puri Rosemarie Preyer Gary S Lee Armin Schwarzbach Source Type: research
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia
CONCLUSION: Anaplasmataceae may play an aetiological role in fibromyalgia.PMID:38375844 | DOI:10.2174/0118715273274091231207101522 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - February 20, 2024 Category: Drugs & Pharmacology Authors: Basant K Puri Rosemarie Preyer Gary S Lee Armin Schwarzbach Source Type: research
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia
CONCLUSION: Anaplasmataceae may play an aetiological role in fibromyalgia.PMID:38375844 | DOI:10.2174/0118715273274091231207101522 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - February 20, 2024 Category: Drugs & Pharmacology Authors: Basant K Puri Rosemarie Preyer Gary S Lee Armin Schwarzbach Source Type: research
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia
CONCLUSION: Anaplasmataceae may play an aetiological role in fibromyalgia.PMID:38375844 | DOI:10.2174/0118715273274091231207101522 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - February 20, 2024 Category: Drugs & Pharmacology Authors: Basant K Puri Rosemarie Preyer Gary S Lee Armin Schwarzbach Source Type: research
T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia
CONCLUSION: Anaplasmataceae may play an aetiological role in fibromyalgia.PMID:38375844 | DOI:10.2174/0118715273274091231207101522 (Source: CNS and Neurological Disorders Drug Targets)
Source: CNS and Neurological Disorders Drug Targets - February 20, 2024 Category: Drugs & Pharmacology Authors: Basant K Puri Rosemarie Preyer Gary S Lee Armin Schwarzbach Source Type: research
Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):118-123. doi: 10.15585/mmwr.mm7306a1.ABSTRACTLyme disease, a tickborne zoonosis caused by certain species of Borrelia spirochetes, is the most common vectorborne disease in the United States. Approximately 90% of all cases are reported from 15 high-incidence jurisdictions in the Northeast, mid-Atlantic, and upper-Midwest regions. After the implementation of a revised surveillance case definition in 2022, high-incidence jurisdictions report cases based on laboratory evidence alone, without need for additional clinical information. In 2022, 62,551 Lyme disease cases were reported ...
Source: MMWR Morb Mortal Wkl... - February 15, 2024 Category: Epidemiology Authors: Kiersten J Kugeler Austin Earley Paul S Mead Alison F Hinckley Source Type: research
Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):118-123. doi: 10.15585/mmwr.mm7306a1.ABSTRACTLyme disease, a tickborne zoonosis caused by certain species of Borrelia spirochetes, is the most common vectorborne disease in the United States. Approximately 90% of all cases are reported from 15 high-incidence jurisdictions in the Northeast, mid-Atlantic, and upper-Midwest regions. After the implementation of a revised surveillance case definition in 2022, high-incidence jurisdictions report cases based on laboratory evidence alone, without need for additional clinical information. In 2022, 62,551 Lyme disease cases were reported ...
Source: MMWR Morb Mortal Wkl... - February 15, 2024 Category: Epidemiology Authors: Kiersten J Kugeler Austin Earley Paul S Mead Alison F Hinckley Source Type: research
Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):118-123. doi: 10.15585/mmwr.mm7306a1.ABSTRACTLyme disease, a tickborne zoonosis caused by certain species of Borrelia spirochetes, is the most common vectorborne disease in the United States. Approximately 90% of all cases are reported from 15 high-incidence jurisdictions in the Northeast, mid-Atlantic, and upper-Midwest regions. After the implementation of a revised surveillance case definition in 2022, high-incidence jurisdictions report cases based on laboratory evidence alone, without need for additional clinical information. In 2022, 62,551 Lyme disease cases were reported ...
Source: MMWR Morb Mortal Wkl... - February 15, 2024 Category: Epidemiology Authors: Kiersten J Kugeler Austin Earley Paul S Mead Alison F Hinckley Source Type: research
Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):118-123. doi: 10.15585/mmwr.mm7306a1.ABSTRACTLyme disease, a tickborne zoonosis caused by certain species of Borrelia spirochetes, is the most common vectorborne disease in the United States. Approximately 90% of all cases are reported from 15 high-incidence jurisdictions in the Northeast, mid-Atlantic, and upper-Midwest regions. After the implementation of a revised surveillance case definition in 2022, high-incidence jurisdictions report cases based on laboratory evidence alone, without need for additional clinical information. In 2022, 62,551 Lyme disease cases were reported ...
Source: MMWR Morb Mortal Wkl... - February 15, 2024 Category: Epidemiology Authors: Kiersten J Kugeler Austin Earley Paul S Mead Alison F Hinckley Source Type: research
Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):118-123. doi: 10.15585/mmwr.mm7306a1.ABSTRACTLyme disease, a tickborne zoonosis caused by certain species of Borrelia spirochetes, is the most common vectorborne disease in the United States. Approximately 90% of all cases are reported from 15 high-incidence jurisdictions in the Northeast, mid-Atlantic, and upper-Midwest regions. After the implementation of a revised surveillance case definition in 2022, high-incidence jurisdictions report cases based on laboratory evidence alone, without need for additional clinical information. In 2022, 62,551 Lyme disease cases were reported ...
Source: MMWR Morb Mortal Wkl... - February 15, 2024 Category: Epidemiology Authors: Kiersten J Kugeler Austin Earley Paul S Mead Alison F Hinckley Source Type: research
Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022
MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):118-123. doi: 10.15585/mmwr.mm7306a1.ABSTRACTLyme disease, a tickborne zoonosis caused by certain species of Borrelia spirochetes, is the most common vectorborne disease in the United States. Approximately 90% of all cases are reported from 15 high-incidence jurisdictions in the Northeast, mid-Atlantic, and upper-Midwest regions. After the implementation of a revised surveillance case definition in 2022, high-incidence jurisdictions report cases based on laboratory evidence alone, without need for additional clinical information. In 2022, 62,551 Lyme disease cases were reported ...
Source: MMWR Morb Mortal Wkl... - February 15, 2024 Category: Epidemiology Authors: Kiersten J Kugeler Austin Earley Paul S Mead Alison F Hinckley Source Type: research
Delayed Diagnosis of Locally Acquired Lyme Disease, Central North Carolina, USA
R. M. Boyce et al. (Source: Emerging Infectious Diseases Journal)
Source: Emerging Infectious Diseases Journal - February 14, 2024 Category: Infectious Diseases Source Type: research
The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use
Working together, two major pharmaceutical companies have developed a Lyme disease vaccine consisting of recombinant-derived outer surface protein A (OspA) of the etiologic agent Borrelia burgdorferi. Multiple clinical trials have shown the vaccine to have good safety and efficacy results, and it is hoped that it would become available for human use at least by the year 2025 after receiving approval from the U.S. Food and Drug Administration. There are still challenges left to ensure that the vaccine has, at most, minimal side effects. Also, because the previously developed Lyme disease vaccine was discontinued in 2002 aft...
Source: Frontiers in Immunology - February 14, 2024 Category: Allergy & Immunology Source Type: research
